Heart Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have had a type of heart attack called a STEMI and arrive at the hospital within 48 hours of their symptoms starting.
Who may not be able to join:
- No specific exclusion criteria have been listed for this trial (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Zhe Zheng, Chinese Academy of Medical Sciences, Fuwai Hospital
Phone: 13910008985
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Aspirin at arrival; Clopidogrel (or ticagrelor) at arrival; β-blockers at arrival; ECG at arrival; Reperfusion therapy rate; Time delay from failure of fibrinolysis to angiography(The time from start of fibrinolysis to evaluation of its efficacy is 60-90min); Time delay from start of fibrinolysis to angiography(if fibrinolysis is successful); Timeliness of thrombolytic therapy; Timeliness of primary PCI; Door-in-Door-Out Time; Time to Primary PCI Among Transferred Patients; Evaluation of LDL-C; Evaluation of left ventricular ejection fraction; Aspirin use during hospitalization; Clopidogrel (o...
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.